The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The opioid use disorder (OUD) market has witnessed significant growth in recent years, with projections indicating continued expansion. This growth trajectory is fueled by various factors, including increased prescription rates, evolving pain management practices, and intensified drug marketing efforts.

Rapid Market Growth: A Statistical Overview

• Market size surged from $3.53 billion in 2023 to $3.93 billion in 2024.
• Compound annual growth rate (CAGR) stands at 11.3%.
• Historic growth attributed to heightened prescription rates, evolving pain management practices, and stigmatization of addiction.

Projections for Future Growth

• Expected to reach $6.04 billion by 2028.
• Regulatory interventions, focus on alternative pain management, and expansion of treatment access driving forecasted growth.
• Major trends include technological innovations, individualized treatment approaches, and community-based support programs.

View More On The Opioid Use Disorder (OUD) Market Report 2024 – https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

Growing Number of Opioid Addiction Cases

• Rise in opioid addiction cases driving market growth.
• Opioid addiction characterized by compulsive and chronic opioid use with harmful effects.
• Continued increase in opioid overdose deaths underscores the urgency of addressing addiction.

Key Players in the Market

• Pfizer Inc., Novartis AG, AstraZeneca plc., among others, are prominent companies in the OUD market.
• Diverse product portfolios cater to different aspects of addiction treatment.
• Recent acquisitions, such as Indivior PLC’s acquisition of Opiant Pharmaceuticals Inc., demonstrate strategic moves to bolster treatment offerings.

FDA Approval of Brixadi: A Milestone in Treatment Innovation

• Brixadi (buprenorphine) extended-release injection approved for moderate to severe OUD.
• Offers flexibility with weekly and monthly dosage forms.
• Illustrates the importance of product innovation in addressing treatment needs.

Segmentation of the OUD Market

• Segmented by drug type, route of administration, age group, and distribution channel.
• Provides insights into diverse patient needs and preferences.
• Enables targeted approaches in treatment and distribution strategies.

Regional Insights: North America Leading the Charge

• North America emerged as the largest region in the OUD market in 2023.
• Reflects the prevalence of opioid addiction and the region’s proactive response to addressing it.
• Offers opportunities for collaboration and knowledge exchange in combating the opioid crisis.

Conclusion: Addressing Opioid Addiction Through Collaborative Efforts The trajectory of the opioid use disorder (OUD) market underscores the urgency of addressing the opioid crisis through innovative treatments, comprehensive public health initiatives, and collaborative efforts across stakeholders. With continued focus on research, development, and access to care, there is hope for mitigating the impact of opioid addiction and improving outcomes for affected individuals and communities.

Request A Sample Of The Global Opioid Use Disorder (OUD) Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=12586&type=smp